Todd Asset Management LLC raised its stake in Express Scripts (NASDAQ:ESRX) by 78.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 326,984 shares of the company’s stock after buying an additional 143,768 shares during the period. Todd Asset Management LLC owned about 0.06% of Express Scripts worth $22,588,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. SeaCrest Wealth Management LLC bought a new position in shares of Express Scripts in the 4th quarter worth $105,000. Aevitas Wealth Management Inc. bought a new position in shares of Express Scripts in the 4th quarter worth $128,000. Financial Gravity Companies Inc. bought a new position in shares of Express Scripts in the 4th quarter worth $142,000. ClariVest Asset Management LLC increased its holdings in shares of Express Scripts by 31,700.0% in the 1st quarter. ClariVest Asset Management LLC now owns 2,226 shares of the company’s stock worth $153,000 after buying an additional 2,219 shares during the last quarter. Finally, Virtue Capital Management LLC bought a new position in shares of Express Scripts in the 4th quarter worth $176,000. 85.82% of the stock is currently owned by hedge funds and other institutional investors.
In other news, VP Everett Neville sold 4,895 shares of the firm’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $75.26, for a total value of $368,397.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christine Houston sold 19,889 shares of the firm’s stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $76.69, for a total transaction of $1,525,287.41. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.
Shares of Express Scripts opened at $76.79 on Friday, MarketBeat.com reports. The firm has a market capitalization of $43.26 billion, a price-to-earnings ratio of 10.82, a PEG ratio of 0.97 and a beta of 0.98. Express Scripts has a 12-month low of $55.80 and a 12-month high of $85.07. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.56 and a current ratio of 0.69.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, May 2nd. The company reported $1.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.76 by $0.01. The business had revenue of $24.77 billion for the quarter, compared to analyst estimates of $24.80 billion. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. The company’s revenue was up .5% on a year-over-year basis. During the same quarter last year, the firm earned $1.33 EPS. research analysts expect that Express Scripts will post 9.07 earnings per share for the current fiscal year.
ESRX has been the topic of a number of research analyst reports. Zacks Investment Research lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a report on Friday, March 2nd. Sanford C. Bernstein lowered shares of Express Scripts from a “market perform” rating to an “underperform” rating and increased their target price for the company from $55.80 to $77.50 in a report on Tuesday, January 30th. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Friday, February 23rd. Jefferies Group set a $91.00 target price on shares of Express Scripts and gave the company a “buy” rating in a report on Wednesday, February 28th. Finally, Bank of America initiated coverage on shares of Express Scripts in a report on Tuesday, February 27th. They set an “underperform” rating and a $77.00 target price on the stock. Four research analysts have rated the stock with a sell rating, twelve have issued a hold rating and six have given a buy rating to the company’s stock. Express Scripts currently has an average rating of “Hold” and an average target price of $82.50.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.